Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04207060 · ClinicalTrials.gov registry record · Phase 1
Trial of Indomethacin in Chronic Pancreatitis
A Phase 1 study of Chronic Pancreatitis, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 2
- Study locations
NCT04207060: Completed Phase 1 study of Chronic Pancreatitis, sponsored by Mayo Clinic.
NCT04207060 is a Phase 1 study of Chronic Pancreatitis that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04207060, a Phase 1 study of Chronic Pancreatitis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.
Primary Outcome
Mean change in PGE2 concentrations in pancreas fluid before and after intervention
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Indomethacin
- PROCEDURE Endoscopy for Pancreatic Function Testing
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2023-04-24 |
| Phase | Phase 1 |
What the finished NCT04207060 record still lists
NCT04207060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04207060 reports a single indexed study location in Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT04207060 about?
NCT04207060 is a clinical study titled "Trial of Indomethacin in Chronic Pancreatitis". The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.
What is the current status of trial NCT04207060?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2020-07-15. Estimated completion is 2023-04-24.
What conditions does trial NCT04207060 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT04207060?
The interventions under investigation include: Placebo (DRUG), Indomethacin (DRUG), Endoscopy for Pancreatic Function Testing (PROCEDURE).
Who is sponsoring clinical trial NCT04207060?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04207060 being conducted?
This trial has 2 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04207060's enrollment target sits among peer trials
27 35th of 42 higher than 8 of 42 other Chronic Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
Soy Tomato Juice to Improve Outcomes in Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Carbon Monoxide-Saturated Medium for Islet Isolation
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI